Symbol="MESO"
AssetType="Common Stock"
Name="Mesoblast Ltd"
Description="Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia."
CIK="1345099"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AU"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="785589000"
EBITDA="-67471000"
PERatio="0.4"
PEGRatio="0"
BookValue="3.275"
DividendPerShare="0"
DividendYield="0"
EPS="12.07"
RevenuePerShareTTM="0.055"
ProfitMargin="0"
OperatingMarginTTM="-9.23"
ReturnOnAssetsTTM="-0.0657"
ReturnOnEquityTTM="-0.163"
RevenueTTM="7586000"
GrossProfitTTM="-53361000"
DilutedEPSTTM="12.07"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.036"
AnalystTargetPrice="10.5"
TrailingPE="0.4"
ForwardPE="833.33"
PriceToSalesRatioTTM="56.79"
PriceToBookRatio="0.93"
EVToRevenue="62.57"
EVToEBITDA="-7.87"
Beta="2.403"
num_52WeekHigh="5.12"
num_52WeekLow="2.53"
num_50DayMovingAverage="3.811"
num_200DayMovingAverage="3.365"
SharesOutstanding="162732000"
DividendDate="None"
ExDividendDate="None"
symbol="MESO"
open="4.79"
high="4.92"
low="4.65"
price="4.80"
volume="294509.00"
latest_trading_day="2023-07-18"
previous_close="4.79"
change="0.01"
change_percent="0.2088%"
aroon_positive_momentum_days="62"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="155675"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_30"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="1138"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0171.jpeg"
image_negative_thumbnail_id_2="109"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0067.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="559"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_positive_thumbnail_id_1="659"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0049.jpeg"
image_positive_thumbnail_id_2="963"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
